These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34332460)

  • 1. Therapeutic plasma exchange in MS refractory relapses: Long-term outcome.
    Marrodan M; Crema S; Rubstein A; Alessandro L; Fernandez J; Correale J; Ysrraelit MC
    Mult Scler Relat Disord; 2021 Oct; 55():103168. PubMed ID: 34332460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic plasma exchange in multiple sclerosis patients with an aggressive relapse: an observational analysis in a high-volume center.
    Bunganic R; Blahutova S; Revendova K; Zapletalova O; Hradilek P; Hrdlickova R; Ganesh A; Cermakova Z; Bar M; Volny O
    Sci Rep; 2022 Nov; 12(1):18374. PubMed ID: 36319704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.
    Ehler J; Koball S; Sauer M; Mitzner S; Hickstein H; Benecke R; Zettl UK
    PLoS One; 2015; 10(8):e0134583. PubMed ID: 26244762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Plasma Exchange to Escalated Methyl Prednisolone in Refractory Multiple Sclerosis Relapses.
    Pfeuffer S; Rolfes L; Bormann E; Sauerland C; Ruck T; Schilling M; Melzer N; Brand M; Pul R; Kleinschnitz C; Wiendl H; Meuth SG
    J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31877873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study.
    Blechinger S; Ehler J; Bsteh G; Winkelmann A; Leutmezer F; Meister S; Santer A; Hecker M; Berger T; Rommer P; Zettl UK
    Ther Adv Neurol Disord; 2021; 14():1756286420975642. PubMed ID: 33552236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate-to-severe relapses of multiple sclerosis.
    Brochet B; Deloire M; Germain C; Ouallet JC; Wittkop L; Dulau C; Perez P; Thevenot F; De Sèze J; Zéphir H; Vermersch P; Pittion S; Debouverie M; Laplaud DA; Clavelou P; Ruet A
    J Clin Apher; 2020 Aug; 35(4):281-289. PubMed ID: 32369661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Plasma Exchange (TPE) Complications in Patients With Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS): A Report From a Tertiary Center.
    Mavandadi S; Moghaddami M; Meysami AP; Sahraian MA; Paybast S; Ghajarzadeh M; Maemodan FG; Nahayati MA; Azimi A
    Neurologist; 2023 Jan; 28(1):1-4. PubMed ID: 35302053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients-A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness.
    Ehler J; Blechinger S; Rommer PS; Koball S; Mitzner S; Hartung HP; Leutmezer F; Sauer M; Zettl UK
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic plasma exchange combined with immunomodulating agents in secondary progressive multiple sclerosis patients.
    Grapsa E; Triantafyllou N; Rombos A; Lagouranis A; Dimopoulos MA
    Ther Apher Dial; 2008 Apr; 12(2):105-8. PubMed ID: 18387157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica.
    Lipphardt M; Mühlhausen J; Kitze B; Heigl F; Mauch E; Helms HJ; Müller GA; Koziolek MJ
    J Clin Apher; 2019 Aug; 34(4):381-391. PubMed ID: 30698295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
    Burton JM; O'Connor PW; Hohol M; Beyene J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006921. PubMed ID: 23235634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange in severe acute relapses of multiple sclerosis - Results from a Portuguese cohort.
    Correia I; Ribeiro JJ; Isidoro L; Batista S; Nunes C; Macário C; Borges C; Tomaz J; Sousa L
    Mult Scler Relat Disord; 2018 Jan; 19():148-152. PubMed ID: 29241141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis.
    Trebst C; Bronzlik P; Kielstein JT; Schmidt BM; Stangel M
    Blood Purif; 2012; 33(1-3):1-6. PubMed ID: 22086365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma exchange in glucocorticosteroid-unresponsive patients with Clinically Isolated Syndrome.
    Ehler J; Koball S; Sauer M; Hickstein H; Mitzner S; Benecke R; Zettl UK
    Ther Apher Dial; 2014 Oct; 18(5):489-96. PubMed ID: 24674271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of steroid unresponsive relapse with plasma exchange in aggressive multiple sclerosis.
    Habek M; Barun B; Puretić Z; Brinar VV
    Ther Apher Dial; 2010 Jun; 14(3):298-302. PubMed ID: 20609182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive parameters of mitoxantrone effectiveness in the treatment of multiple sclerosis.
    Debouverie M; Vandenberghe N; Morrissey SP; Anxionnat R; Pittion-Vouyovitch S; Vespignani H; Edan G
    Mult Scler; 2004 Aug; 10(4):407-12. PubMed ID: 15327038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-related Hospitalizations: Integrated Analysis of the Delayed-release Dimethyl Fumarate Phase III Studies.
    Giovannoni G; Gold R; Fox RJ; Kappos L; Kita M; Yang M; Sarda SP; Zhang R; Viglietta V; Havrdova E
    Clin Ther; 2015 Nov; 37(11):2543-51. PubMed ID: 26526385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world effectiveness of fingolimod in Polish group of patients with relapsing-remitting multiple sclerosis.
    Walczak A; Kurkowska-Jastrzebska I; Zakrzewska-Pniewska B; Dorobek M; Brola W; Zajdel R; Bartosik-Psujek H; Stasiolek M; Kulakowska A; Rusek S; Tutaj A; Glabinski A; Wlodek A; Kochanowski J; Ciach A; Siger M; Kurowska K; Wicha W; Nojszewska M; Podlecka-Pietowska A; Czajka A; Kapica-Topczewska K; Bielecki B; Maciagowska-Terela M; Stepien A
    Clin Neurol Neurosurg; 2019 Sep; 184():105453. PubMed ID: 31376776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.